Navamedic finalizes rights issue details for capital raise

Navamedic ASA has provided updated key information for its contemplated partly underwritten rights issue. The company aims to issue a maximum of 6,046,511 new shares at a subscription price of 21.50 Norwegian krone per share. Existing shareholders as of July 14, 2025 (record date July 16, 2025) will receive 0.34233 subscription rights for each share held, rounded down to the nearest whole right. The subscription ratio is 1:1, meaning one new share per subscription right.

The subscription rights will be listed on Euronext Oslo Børs under the ticker "NAVAT". The rights issue is contingent on the publication of a prospectus, expected around September 19, 2025, following approval by the Norwegian Financial Supervisory Authority. DNB Carnegie and Nordea Corporate Finance are acting as managers for the rights issue.